Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Long WS Wide: или про то, как выполнить анализ разницы изменений между группами
Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0

Галерея

Human medicines European public assessment report (EPAR): Hyftor, sirolimus, Date of authorisation: 15/05/2023, Revision: 3, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 22, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Human medicines European public assessment report (EPAR): Strimvelis, autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence, Date of authorisation: 26/05/2016, Revision: 12, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Human medicines European public assessment report (EPAR): ProQuad, measles, mumps, rubella and varicella vaccine (live), Date of authorisation: 05/04/2006, Revision: 34, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Human medicines European public assessment report (EPAR): Jivi, damoctocog alfa pegol, Date of authorisation: 22/11/2018, Revision: 6, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Human medicines European public assessment report (EPAR): Palforzia, defatted powder of Arachis hypogaea L., semen (peanuts), Date of authorisation: 17/12/2020, Revision: 10, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Human medicines European public assessment report (EPAR): Rilonacept FGK Representative Service GmbH , rilonacept, Status: Application withdrawn
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Procedural guidance to scientific committeesꞌ members and experts on completing the European Medicines Agencyꞌs declaration of interests in the Experts Management Tool
Source: EMA - Regulatory and procedural guidelines (human and veterinary) Published on 2025-07-04
Human medicines European public assessment report (EPAR): Orfadin, nitisinone, Date of authorisation: 21/02/2005, Revision: 22, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Human medicines European public assessment report (EPAR): Neoatricon, dopamine hydrochloride, Date of authorisation: 27/05/2024, Revision: 1, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Human medicines European public assessment report (EPAR): Leflunomide medac, leflunomide, Date of authorisation: 27/07/2010, Revision: 24, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-07-04
Information by Drug Class
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-03 By FDA
Registered Outsourcing Facilities
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-03 By FDA
AFLURIA , AFLURIA SOUTHERN HEMISPHERE
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-07-03 By FDA
Exela Pharma Sciences, LLC - 709859 - 07/02/2025
Source: FDA - What's New: Drugs RSS Feed Published on 2025-07-03 By FDA

Предыдущие записи

Тема: Scaffold от Danny Cooper.